The Affiliated Hospital of Qingdao University — Qingdao, Shandong

Public research footprint of The Affiliated Hospital of Qingdao University, compiled from the ClinicalTrials.gov public registry.

382

Registered studies

170

Active

Recruiting now

121

Completed

Stopped or withdrawn

Most-studied conditions

Unresectable or Metastatic Gastric or Gastroesophageal Junction… · Non-small Cell Lung Cancer · Relapsed/Refractory Follicular Lymphoma · Advanced Hepatocellular Carcinoma (HCC)

Recently updated registry entries

NCT07127822 — Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric… (Recruiting)
NCT07111520 — A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327… (Recruiting)
NCT07725484 — Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Affiliated Hospital of Qingdao University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.